8h30 Welcome

9:00-10:30 – Chairs : J Perinel – A Sa Cunha – A Sauvanet

• G NAPPO – Incidence of PPH after pancrearticoduodenectomy. Current evidence on risk factors and predictive models for PPH, so you can better identify high-risk patients preoperatively.
• R SALVIA – Surgical techniques associated with an increased risk of PPH in patients undergoing pancreaticoduodenectomy. What is the most frequent site of PPH after pancreaticoduodenectomy.
• G CASSESE – Impact of pancreatic transection techniques and remnant volume on PPH in distal pancreatectomy
• A Sa CUNHA – Preventive methods to reduce the incidence and severity of PPH after pancreaticoduodenectomy.

10:30-11:00 Coffee break

11:00-12:30 – Chairs : G Nappo – J Navez – R Salvia 

• H FRIESS – Anticoagulants (such as low-molecular-weight heparin) and antiplatelet agents are pharmacologic agents associated with an increased risk of bleeding in patients undergoing pancreaticoduodenectomy.
• XJ TAVERNA – Multidisciplinary critical care/ICU aspects in severe PPH (resuscitation, massive transfusion protocols, coagulopathy reversal).
• FG UZUNOGLU – Current best practices for the diagnosis and management of hemorrhage from the gastroduodenal artery stump, including the role of imaging and interventional radiology.
• D BASSI – Role of a hemostatic patches in pancreatic surgery, the Padova experience.
• R VELLA – Hemostatic patches for reducing PPH risk and severity: feasibility and preliminary results.

12h30-14:00 Lunch

14:00-16h00 – Chairs : H Freiss – I Frigerio – F Panaro

• F BORGES – Post-Pancreatectomy Hemorrhage: Risk factors & outcomes.
• I FRIGERIO – PPH : ISGPS definition & grading – A critical appraisal.
• J PERINEL – Prospective study protocol discussion : can we reduce the incidence & severity of PPH.